SALA, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 10.661
NA - Nord America 8.748
AS - Asia 8.497
SA - Sud America 792
AF - Africa 153
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.888
Nazione #
US - Stati Uniti d'America 8.501
IT - Italia 3.241
GB - Regno Unito 3.141
SG - Singapore 2.525
CN - Cina 2.515
RU - Federazione Russa 904
DE - Germania 877
VN - Vietnam 706
HK - Hong Kong 703
SE - Svezia 593
BR - Brasile 582
BD - Bangladesh 482
TR - Turchia 422
FR - Francia 403
NL - Olanda 377
IN - India 336
KR - Corea 315
IE - Irlanda 263
FI - Finlandia 256
UA - Ucraina 173
CA - Canada 162
EU - Europa 138
ID - Indonesia 128
DK - Danimarca 96
JP - Giappone 92
AR - Argentina 60
CO - Colombia 56
GR - Grecia 55
CH - Svizzera 48
CI - Costa d'Avorio 47
MX - Messico 45
PL - Polonia 43
IQ - Iraq 38
ES - Italia 32
PH - Filippine 31
BE - Belgio 30
AT - Austria 28
AU - Australia 28
EC - Ecuador 27
RO - Romania 23
MY - Malesia 22
PK - Pakistan 22
ZA - Sudafrica 22
CL - Cile 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
IR - Iran 17
EG - Egitto 14
VE - Venezuela 14
MA - Marocco 13
TW - Taiwan 13
AL - Albania 12
IL - Israele 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
NO - Norvegia 11
NP - Nepal 11
PE - Perù 11
PY - Paraguay 11
TN - Tunisia 10
KE - Kenya 9
KZ - Kazakistan 9
CZ - Repubblica Ceca 8
HR - Croazia 8
SC - Seychelles 8
BY - Bielorussia 6
CR - Costa Rica 6
DZ - Algeria 6
JM - Giamaica 5
LU - Lussemburgo 5
PT - Portogallo 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KG - Kirghizistan 4
LB - Libano 4
LT - Lituania 4
NZ - Nuova Zelanda 4
AM - Armenia 3
AO - Angola 3
CG - Congo 3
CY - Cipro 3
ET - Etiopia 3
HU - Ungheria 3
MD - Moldavia 3
OM - Oman 3
SV - El Salvador 3
BB - Barbados 2
FK - Isole Falkland (Malvinas) 2
HN - Honduras 2
KW - Kuwait 2
LY - Libia 2
MN - Mongolia 2
PA - Panama 2
PS - Palestinian Territory 2
Totale 28.982
Città #
Southend 2.913
Singapore 1.369
Ashburn 837
Hong Kong 662
Milan 638
San Jose 575
Chandler 547
Seattle 534
Beijing 501
Santa Clara 385
Wilmington 362
Princeton 353
Fairfield 316
Dallas 297
Council Bluffs 283
Dublin 261
Ho Chi Minh City 241
Rome 209
Redmond 188
Los Angeles 182
New York 177
Woodbridge 165
Hanoi 164
Ann Arbor 161
Lauterbourg 156
Houston 155
Munich 155
Nanjing 147
Mountain View 145
Buffalo 144
Guangzhou 134
Dearborn 126
Sakarya 126
Bengaluru 117
Cambridge 117
Des Moines 110
Frankfurt am Main 109
Jacksonville 98
Toronto 95
Boardman 92
Shanghai 90
Helsinki 87
Moscow 82
Jinan 73
Jakarta 70
Tianjin 69
Grafing 68
São Paulo 64
Tokyo 60
Hefei 57
Shenyang 56
Phoenix 55
Columbus 52
Redwood City 52
The Dalles 51
Seoul 50
Padova 49
Abidjan 47
Berlin 47
Istanbul 46
Naples 46
Andover 44
Serra 44
Shenzhen 44
Nanchang 43
Turin 43
San Diego 41
Athens 40
Cangzhou 40
Hangzhou 40
Bogotá 38
Catania 36
Changsha 36
Eitensheim 35
Hebei 34
Palermo 33
Verona 33
London 31
Chicago 30
Fuzhou 30
Parma 30
Warsaw 30
Jiaxing 29
Somerville 28
Da Nang 27
Pavia 27
Saint Petersburg 27
Bitonto 26
Dong Ket 26
Cagliari 25
Florence 25
Zhengzhou 25
Sunnyvale 24
Bologna 23
Wuhan 23
Brussels 22
Haikou 22
Montreal 22
Pune 22
Washington 22
Totale 16.837
Nome #
English for pharmacy : biotechnologies, drugs, natural remedies and cosmetics 979
Droghe e farmaci psicoattivi 869
Stress ossidativo nella s. di Down : determinazione dell'8-isoprostano nell'esalato, nel siero e nelle urine 427
Proanthocyanidins from Vitis vinifera inhibit oxidative stress-induced vascular impairment in pulmonary arteries from diabetic rats 411
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 398
CHF6001 Inhibits NF-κB activation and neutrophilic recruitment in LPS-induced lung inflammation in mice 366
Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease 365
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation 337
5-Lipoxygenase activity, lipid peroxidation and the effect of antioxidant treatment in COPD subjects 294
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice 290
Antiinflammatory and antioxidant effects of H2O2 generated by natural sources in Il1β-treated human endothelial cells 290
Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor 285
Prostaglandin E2 possesses different potencies in inducing Vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts 277
Continuous wound infusion with chloroprocaine in a pig model of surgical lesion : Drug absorption and effects on inflammatory response 275
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice 273
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells : Crucial role of 5-lipoxygenase 264
Biomarkers of inflammation and oxidative stress in patients with COPD and healthy smokers 253
Bioactive Compounds in Edible Oils and Their Role in Oxidative Stress and Inflammation 252
Montelukast Use Decreases Cardiovascular Events in Asthmatics 249
14, 15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase. 248
Biosintesi transcellulare degli eicosanoidi: un efficace sistema di bioamplificazione 248
MicroRNA 143-145 deficiency impairs vascular function 247
Leukotriene E4 elimination and metabolism in normal human subjects 246
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: signaling through the CysLT2 receptor 245
Antagonism of thromboxane receptors by diclofenac and lumiracoxib 243
Blood fatty acids profile in mis-c children 234
Le basi farmacologiche della terapia 233
Azithromycin inhibits nuclear factor-κB activation during lung inflammation : an in vivo imaging study 233
The Atlas of Inflammation Resolution (AIR) 233
Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase 226
Principi di farmacologia : classificazione, interazioni, indicazioni cliniche 226
Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery 224
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain 217
Leukotriene synthesis and lipid peroxidation in COPD subjects 217
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain 216
Effects of mediterranean diet or low-fat diet on blood fatty acids in patients with coronary heart disease. A randomized intervention study 215
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. 213
Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. 213
Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis 212
From field to health : a simple way to increase the nutraceutical content of grape ss shown by NO-Dependent vascular relaxation 210
Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness 210
Le basi farmacologiche della terapia 210
Le basi farmacologiche della terapia : il manuale 208
Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model 208
eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetics 206
Bioavailability of curcumin in the rat frontal lobe and hippocampus after repeated administration of MERIVA® 206
Role of sodium in intracellular calcium elevation and leukotriene B4 formation by agonist activated human neutrophils 201
Droghe e farmaci psicoattivi 200
beta2 Integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes 195
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile 195
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. 193
Eosinophil 15-lipoxygenase is a leukotriene A4 synthase. 193
Farmaci per il sistema respiratorio 191
Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone 189
Olive Phenol Hydroxytyrosol Prevents Passive Smoking--Induced Oxidative Stress 189
null 188
Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade 187
A new class of nitric oxide-releasing derivatives of cetirizine; pharmacological profile in vascular and airway smooth muscle preparations 182
15-Lipoxygenase expression and 15 (S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects 182
Bronchodilators Modulate Inflammation In Chronic Obstructive Pulmonary Disease Subjects 181
Principi di farmacologia : classificazione, interazioni, indicazioni cliniche 180
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration 180
Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart 176
Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress 176
15 (S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis 176
Transcellular biosynthesis of eicosanoid lipid mediators 174
Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk 174
Negative ion tandem mass spectrometry of leukotriene E4 and LTE4 metabolites: Identification of LTE4 in human urine 173
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends 172
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype 171
Profile of COX-2 and PGI2 in human diabetic versus high glucose treated endothelial cells 171
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1, 3-benzenedicarboxamide](2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature 171
Dual COXIB/TP antagonists : a possible new twist in NSAID pharmacology and cardiovascular risk 169
Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis 168
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 167
Muscarinic receptors, leukotriene B-4 production and neutrophilic inflammation in COPD patients 167
Transcellular byosynthesis of eicosanoids 167
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition 167
Mediator release after endobronchial antigen challenge in patients with respiratory allergy 166
Exploratory study of the effect of DHA supplementation on blood fatty acids and inflammatory markers in children with MIS-C 163
Treatment with natural anti-oxidants from vitis vinifera decreases lipid peroxidation in non insulin-dependent diabetics 163
The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat 161
Unsaturated fatty acids, omega-3 index and hospitalization in MISC 159
Citrus flavonoids effects on human umbilical vein 156
Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. 155
Pharmacological modulation of the leukotriene pathway in allergic airway disease 152
Pharmacological characterization of 2NTX-99, a potential antiatherothrombotic agent with antithromboxane and no-donor activity 152
Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults with cystic fibrosis? 152
Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation 151
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors 151
Mediators and allergic inflammation of human airways 151
Transcellular metabolism of leukotriene A4 by rabbit blood cells: lack of relevant LTC4-synthase activity in rabbit platelets. 150
Endothelial-dependent dynamic and antithrombotic properties of porcine aortic and pulmonary valves 149
Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: Different degrees of responsiveness in atopic and nonatopic subjects 149
IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases 148
Cysteinyl leukotrienes receptor activation in brain inflammatory reactions and oedema formation: a role for transcellular biosynthesis of cys-leukotrienes 147
EFFECTS OF LORATADINE ON CYTOSOLIC CA2+ LEVELS AND LEUKOTRIENE RELEASE - NOVEL MECHANISMS OF ACTION INDEPENDENT OF THE ANTIHISTAMINE ACTIVITY 146
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes. 140
Comparison of short-term antioxidant effects of statins: a randomized prospective study on atherosclerotic patients. 139
Antioxidant modulation of cyclooxygenase-2 in human bronchial smooth muscle cells 139
Totale 22.305
Categoria #
all - tutte 81.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.996 201 115 54 83 234 142 129 121 196 205 154 362
2022/20232.149 287 173 196 208 232 454 55 170 203 33 74 64
2023/20241.471 47 113 87 98 343 76 75 96 70 86 166 214
2024/20254.216 157 371 90 457 447 195 154 471 229 333 362 950
2025/20268.809 799 449 919 697 738 608 953 559 967 616 784 720
2026/2027188 188 0 0 0 0 0 0 0 0 0 0 0
Totale 30.349